Eubelius assists Crédit Mutuel Innovation and Debiopharm Innovation Fund in connection with their investment in Oncomfort SA

News
9 September 2020
Corporate and M&A

Eubelius acted as legal counsel to Crédit Mutuel Innovation and Debiopharm Innovation Fund in connection with their investment in Oncomfort SA.

Oncomfort SA is a Belgian company based in Wavre which develops and markets digital solutions utilising virtual reality, augmented reality or mixed reality for anaesthesia and the treatment of stress, anxiety and pain. It also aims to develop and market tools for measuring the state of consciousness, stress, anxiety and pain.

The Eubelius team consisted of Erwin Destuyver, Jan Loosen and Luana Huybrechts.

For more details: 
French: Press article L'Echo / Press article La Libre

Dutch: Press article De Tijd / Press article Knack

 

Erwin Destuyver

Partner

Eubelius assists The Organic Consumer Group with the acquisition of La Saponaria

Eubelius assisted The Organic Consumer Group (a Damier company) with its acquisition of La Saponaria, an Italian producer and distributor of...

Practices that M&A dealmakers should avoid: European courts clarify the concept of “gun jumping”

The Court of Justice of the EU (“CJEU”) has clarified which pre-closing veto rights and conduct should be avoided by parties to an M&A...

Changes in accounting treatment for new merger and demerger operations

The Royal Decree of 26 November 2023 regulates the accounting treatment of the new operations assimilated to mergers and demergers made...